Ten years of rizatriptan: From development to clinical science and future directions

Richard J. Hargreaves; Chris R. Lines; Alan M. Rapoport; Tony W. Ho; Fred D. Sheftell

doi:10.1111/j.1526-4610.2008.01335.x

Ten years of rizatriptan: From development to clinical science and future directions

Richard J. Hargreaves, Chris R. Lines, Alan M. Rapoport, Tony W. Ho, Fred D. Sheftell

School of Medicine

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Abstract

The year 2008 marked the 10th anniversary since rizatriptan was first launched for the acute treatment of migraine. In this article we discuss the concepts that motivated the preclinical and clinical development of rizatriptan, the clinical evidence that has driven its use over the past decade, rizatriptan's overall contribution to the field, and future directions for research.

Original language	English (US)
Pages (from-to)	S3-S20
Journal	Headache
Volume	49
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1111/j.1526-4610.2008.01335.x
State	Published - Feb 1 2009

Keywords

Clinical science
Development
Rizatriptan

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1111/j.1526-4610.2008.01335.x

Cite this

@article{8a69d3fc592e4938b4146df421f3aaf2,

title = "Ten years of rizatriptan: From development to clinical science and future directions",

abstract = "The year 2008 marked the 10th anniversary since rizatriptan was first launched for the acute treatment of migraine. In this article we discuss the concepts that motivated the preclinical and clinical development of rizatriptan, the clinical evidence that has driven its use over the past decade, rizatriptan's overall contribution to the field, and future directions for research.",

keywords = "Clinical science, Development, Rizatriptan",

author = "Hargreaves, {Richard J.} and Lines, {Chris R.} and Rapoport, {Alan M.} and Ho, {Tony W.} and Sheftell, {Fred D.}",

year = "2009",

month = feb,

day = "1",

doi = "10.1111/j.1526-4610.2008.01335.x",

language = "English (US)",

volume = "49",

pages = "S3--S20",

journal = "Headache",

issn = "0017-8748",

publisher = "Wiley-Blackwell",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Ten years of rizatriptan

T2 - From development to clinical science and future directions

AU - Hargreaves, Richard J.

AU - Lines, Chris R.

AU - Rapoport, Alan M.

AU - Ho, Tony W.

AU - Sheftell, Fred D.

PY - 2009/2/1

Y1 - 2009/2/1

N2 - The year 2008 marked the 10th anniversary since rizatriptan was first launched for the acute treatment of migraine. In this article we discuss the concepts that motivated the preclinical and clinical development of rizatriptan, the clinical evidence that has driven its use over the past decade, rizatriptan's overall contribution to the field, and future directions for research.

AB - The year 2008 marked the 10th anniversary since rizatriptan was first launched for the acute treatment of migraine. In this article we discuss the concepts that motivated the preclinical and clinical development of rizatriptan, the clinical evidence that has driven its use over the past decade, rizatriptan's overall contribution to the field, and future directions for research.

KW - Clinical science

KW - Development

KW - Rizatriptan

UR - http://www.scopus.com/inward/record.url?scp=58649110408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58649110408&partnerID=8YFLogxK

U2 - 10.1111/j.1526-4610.2008.01335.x

DO - 10.1111/j.1526-4610.2008.01335.x

M3 - Review article

C2 - 19161563

AN - SCOPUS:58649110408

SN - 0017-8748

VL - 49

SP - S3-S20

JO - Headache

JF - Headache

IS - SUPPL. 1

ER -

Ten years of rizatriptan: From development to clinical science and future directions

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this